Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1.01
LTS:0QQD's Cash to Debt is ranked higher than
63% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. LTS:0QQD: 1.01 )
LTS:0QQD' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 1.01

Equity to Asset 0.67
LTS:0QQD's Equity to Asset is ranked higher than
74% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. LTS:0QQD: 0.67 )
LTS:0QQD' s 10-Year Equity to Asset Range
Min: 0.03   Max: 0.84
Current: 0.67

0.03
0.84
Interest Coverage 14.77
LTS:0QQD's Interest Coverage is ranked higher than
56% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 155.33 vs. LTS:0QQD: 14.77 )
LTS:0QQD' s 10-Year Interest Coverage Range
Min: 14.37   Max: 9999.99
Current: 14.77

14.37
9999.99
F-Score: 5
Z-Score: 5.59
M-Score: -2.60
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 23.28
LTS:0QQD's Operating margin (%) is ranked higher than
95% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 6.29 vs. LTS:0QQD: 23.28 )
LTS:0QQD' s 10-Year Operating margin (%) Range
Min: 21.07   Max: 33.34
Current: 23.28

21.07
33.34
Net-margin (%) 16.92
LTS:0QQD's Net-margin (%) is ranked higher than
92% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 5.11 vs. LTS:0QQD: 16.92 )
LTS:0QQD' s 10-Year Net-margin (%) Range
Min: 12.71   Max: 23.87
Current: 16.92

12.71
23.87
ROE (%) 12.71
LTS:0QQD's ROE (%) is ranked higher than
86% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 5.84 vs. LTS:0QQD: 12.71 )
LTS:0QQD' s 10-Year ROE (%) Range
Min: 10.46   Max: 115.87
Current: 12.71

10.46
115.87
ROA (%) 8.38
LTS:0QQD's ROA (%) is ranked higher than
87% of the 393 Companies
in the Global Medical Devices industry.

( Industry Median: 3.49 vs. LTS:0QQD: 8.38 )
LTS:0QQD' s 10-Year ROA (%) Range
Min: 7.56   Max: 32.15
Current: 8.38

7.56
32.15
ROC (Joel Greenblatt) (%) 39.44
LTS:0QQD's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 12.42 vs. LTS:0QQD: 39.44 )
LTS:0QQD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 35.96   Max: 119.58
Current: 39.44

35.96
119.58
Revenue Growth (%) 8.60
LTS:0QQD's Revenue Growth (%) is ranked higher than
81% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. LTS:0QQD: 8.60 )
LTS:0QQD' s 10-Year Revenue Growth (%) Range
Min: 8.6   Max: 25.6
Current: 8.6

8.6
25.6
EBITDA Growth (%) 9.40
LTS:0QQD's EBITDA Growth (%) is ranked higher than
85% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: -2.40 vs. LTS:0QQD: 9.40 )
LTS:0QQD' s 10-Year EBITDA Growth (%) Range
Min: 3.1   Max: 39.6
Current: 9.4

3.1
39.6
EPS Growth (%) 14.30
LTS:0QQD's EPS Growth (%) is ranked higher than
86% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. LTS:0QQD: 14.30 )
LTS:0QQD' s 10-Year EPS Growth (%) Range
Min: -3.1   Max: 41.7
Current: 14.3

-3.1
41.7
» LTS:0QQD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

Latest Guru Trades with LTS:0QQD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.90
0QQD's P/E(ttm) is ranked higher than
88% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 55.30 vs. 0QQD: 21.90 )
0QQD' s 10-Year P/E(ttm) Range
Min: 9.08   Max: 61.06
Current: 21.9

9.08
61.06
P/B 2.61
0QQD's P/B is ranked higher than
75% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. 0QQD: 2.61 )
0QQD' s 10-Year P/B Range
Min: 1.31   Max: 6.26
Current: 2.61

1.31
6.26
P/S 3.71
0QQD's P/S is ranked higher than
64% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. 0QQD: 3.71 )
0QQD' s 10-Year P/S Range
Min: 1.82   Max: 8.95
Current: 3.71

1.82
8.95
PFCF 23.91
0QQD's PFCF is ranked higher than
88% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 23.91 )
0QQD' s 10-Year PFCF Range
Min: 9.54   Max: 50.48
Current: 23.91

9.54
50.48
EV-to-EBIT 15.67
0QQD's EV-to-EBIT is ranked higher than
90% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 37.22 vs. 0QQD: 15.67 )
0QQD' s 10-Year EV-to-EBIT Range
Min: 6.8   Max: 45.8
Current: 15.67

6.8
45.8
PEG 2.67
0QQD's PEG is ranked higher than
93% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 2.67 )
0QQD' s 10-Year PEG Range
Min: 0.45   Max: 5.43
Current: 2.67

0.45
5.43
Shiller P/E 24.76
0QQD's Shiller P/E is ranked higher than
92% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 24.76 )
0QQD' s 10-Year Shiller P/E Range
Min: 10.71   Max: 39.06
Current: 24.76

10.71
39.06
Current Ratio 4.44
0QQD's Current Ratio is ranked higher than
84% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. 0QQD: 4.44 )
0QQD' s 10-Year Current Ratio Range
Min: 1.14   Max: 5.09
Current: 4.44

1.14
5.09
Quick Ratio 3.23
0QQD's Quick Ratio is ranked higher than
81% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 2.07 vs. 0QQD: 3.23 )
0QQD' s 10-Year Quick Ratio Range
Min: 0.71   Max: 3.69
Current: 3.23

0.71
3.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.61
0QQD's Dividend Yield is ranked lower than
72% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.26 vs. 0QQD: 0.61 )
0QQD' s 10-Year Dividend Yield Range
Min: 0.28   Max: 1.1
Current: 0.61

0.28
1.1
Dividend Payout 0.10
0QQD's Dividend Payout is ranked higher than
99% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 0.10 )
0QQD' s 10-Year Dividend Payout Range
Min: 0.15   Max: 0.23
Current: 0.1

0.15
0.23
Yield on cost (5-Year) 0.61
0QQD's Yield on cost (5-Year) is ranked lower than
69% of the 186 Companies
in the Global Medical Devices industry.

( Industry Median: 1.41 vs. 0QQD: 0.61 )
0QQD' s 10-Year Yield on cost (5-Year) Range
Min: 0.28   Max: 1.1
Current: 0.61

0.28
1.1
Share Buyback Rate 5.10
0QQD's Share Buyback Rate is ranked higher than
98% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. 0QQD: 5.10 )
0QQD' s 10-Year Share Buyback Rate Range
Min: 6.6   Max: -8.4
Current: 5.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.28
0QQD's Price/Tangible Book is ranked higher than
70% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 5.89 vs. 0QQD: 5.28 )
0QQD' s 10-Year Price/Tangible Book Range
Min: 4.19   Max: 233.33
Current: 5.28

4.19
233.33
Price/DCF (Projected) 1.15
0QQD's Price/DCF (Projected) is ranked higher than
93% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 17.20 vs. 0QQD: 1.15 )
0QQD' s 10-Year Price/DCF (Projected) Range
Min: 0.58   Max: 1.74
Current: 1.15

0.58
1.74
Price/Median PS Value 1.06
0QQD's Price/Median PS Value is ranked higher than
74% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. 0QQD: 1.06 )
0QQD' s 10-Year Price/Median PS Value Range
Min: 0.58   Max: 2.67
Current: 1.06

0.58
2.67
Price/Peter Lynch Fair Value 2.98
0QQD's Price/Peter Lynch Fair Value is ranked higher than
93% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. 0QQD: 2.98 )
0QQD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.66   Max: 3.1
Current: 2.98

0.66
3.1
Price/Graham Number 2.24
0QQD's Price/Graham Number is ranked higher than
82% of the 416 Companies
in the Global Medical Devices industry.

( Industry Median: 6.47 vs. 0QQD: 2.24 )
0QQD' s 10-Year Price/Graham Number Range
Min: 1.36   Max: 22.07
Current: 2.24

1.36
22.07
Earnings Yield (Greenblatt) 6.40
0QQD's Earnings Yield (Greenblatt) is ranked higher than
83% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. 0QQD: 6.40 )
0QQD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.2   Max: 14.7
Current: 6.4

2.2
14.7
Forward Rate of Return (Yacktman) 10.80
0QQD's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.34 vs. 0QQD: 10.80 )
0QQD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 8.9   Max: 43
Current: 10.8

8.9
43

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:ZMH.Switzerland, ZMH.USA, ZIM.Germany
Zimmer Holdings, Inc., a Delaware corporation was incorporated in 2001. The Company designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provides other healthcare related services. It has operations in more than 25 countries and market products in more than 100 countries. The Company manages its operations through three major geographic segments - the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised mainly of Japan and Australia and includes other Asian and Pacific markets. It markets and sells products through three principal channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories. The Company's products include orthopaedic reconstructive implants, spinal and trauma devices, biologics, dental implants and related surgical products. Orthopaedic reconstructive implants include Knee Implants, Hip Implants and Extremity implants. Total knee replacement surgeries typically include a femoral component, a patella a tibial tray and an articular surface. Total hip replacement surgeries replace both the head of the femur and the socket portion of the pelvis of the natural hip. Its extremity portfolio, mainly shoulder and elbow products, is designed to treat arthritic conditions, soft tissue injuries and fractures, as well as to enhance the outcome of main or revision surgery. Trauma products include devices used to stabilize damaged or broken bones and their surrounding tissues to support the body's natural healing processes. Spine products division designs, manufactures and distributes medical devices and surgical instruments to deliver comprehensive solutions for those with back or neck pain caused by degenerative conditions, deformities or traumatic injury of the spine. The Company's Biologics group based in Austin, Texas works on biological solutions to repair and regenerate damaged or degenerated musculoskeletal tissues using biomaterials/cell therapies which offer the possibility of treating damaged joints by biological repair rather than replacing them. The Company's dental products division manufactures and distributes: dental reconstructive implants - for individuals who are totally without teeth or are missing one or more teeth; dental restorative products - aimed at providing a more natural restoration to mimic the original teeth and dental regenerative products - for soft tissue and bone rehabilitation. The Company develops, manufactures and markets products that support its reconstructive, trauma, spine and dental implant procedures, with a focus on bone cements, surgical wou

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK